AG-024322, with the CAS number 837364-57-5, is a chemical compound that has garnered interest in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized as a small molecule inhibitor, specifically targeting certain protein kinases, which play crucial roles in various cellular processes, including cell growth and division. The compound is typically studied for its efficacy in inhibiting cancer cell proliferation and may exhibit selectivity towards specific cancer types. Its molecular structure includes functional groups that contribute to its biological activity and solubility properties. AG-024322 is often evaluated in preclinical studies to assess its pharmacokinetics, toxicity, and overall therapeutic potential. As with many investigational compounds, detailed information regarding its mechanism of action, side effects, and clinical applications is subject to ongoing research and may evolve as new data becomes available.

AG-024322

837364-57-5: AG-024322, with the CAS number 837364-57-5, is a chemical compound that has garnered interest in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized as a small molecule inhibitor, specifically targeting certain protein kinases, which play crucial roles in various cellular processes, including cell growth and division. The compound is typically studied for its efficacy in inhibiting cancer cell proliferation and may exhibit selectivity towards specific cancer types. Its molecular structure includes functional groups that contribute to its biological activity and solubility properties. AG-024322 is often evaluated in preclinical studies to assess its pharmacokinetics, toxicity, and overall therapeutic potential. As with many investigational compounds, detailed information regarding its mechanism of action, side effects, and clinical applications is subject to ongoing research and may evolve as new data becomes available.

AG-024322 is an analog of a Chinese medicinal herb that has been found to have potent anticancer properties. It works by inhibiting cyclin-dependent kinases, which are enzymes that regulate the cell cycle and play a crucial role in cancer cell growth. AG-024322 has been shown to induce apoptosis, or programmed cell death, in cancer cells. This inhibitor of protein kinase has also demonstrated efficacy against various types of tumors in human studies. AG-024322 is one of several promising inhibitors of this class currently being developed as potential cancer treatments.

AG-024322 is a pan-CDK inhibitor with antitumor activity, induces apoptosis, and can be used in the study of metabolic diseases.

CAS 837364-57-5

AG-024322

AG-024322

Ref: 54-BUP21882

AG-024322

Ref: 3D-MIB36457

AG-024322

Ref: TM-T14136